Your browser doesn't support javascript.
loading
A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics.
Li, Jianke; Trone, Denise; Mendell, Jeanne; O'Donnell, Patrick; Cook, Natalie.
Affiliation
  • Li J; Daiichi Sankyo, Inc., 10201 Wateridge Circle, Suite 240, San Diego, CA, 92121, USA. jiankelius@yahoo.com.
  • Trone D; Daiichi Sankyo, Inc., 10201 Wateridge Circle, Suite 240, San Diego, CA, 92121, USA.
  • Mendell J; Daiichi Sankyo, Inc., Basking Ridge, NJ, USA.
  • O'Donnell P; Daiichi Sankyo, Inc., 10201 Wateridge Circle, Suite 240, San Diego, CA, 92121, USA.
  • Cook N; Daiichi Sankyo, Inc., 10201 Wateridge Circle, Suite 240, San Diego, CA, 92121, USA.
Cancer Chemother Pharmacol ; 84(4): 799-807, 2019 10.
Article in En | MEDLINE | ID: mdl-31385001

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Benzothiazoles / Lansoprazole Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Benzothiazoles / Lansoprazole Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Alemania